These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8702696)

  • 1. The K65R mutation confers increased DNA polymerase processivity to HIV-1 reverse transcriptase.
    Arion D; Borkow G; Gu Z; Wainberg MA; Parniak MA
    J Biol Chem; 1996 Aug; 271(33):19860-4. PubMed ID: 8702696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The K65R mutant reverse transcriptase of HIV-1 cross-resistant to 2', 3'-dideoxycytidine, 2',3'-dideoxy-3'-thiacytidine, and 2',3'-dideoxyinosine shows reduced sensitivity to specific dideoxynucleoside triphosphate inhibitors in vitro.
    Gu Z; Fletcher RS; Arts EJ; Wainberg MA; Parniak MA
    J Biol Chem; 1994 Nov; 269(45):28118-22. PubMed ID: 7525567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutated K65R recombinant reverse transcriptase of human immunodeficiency virus type 1 shows diminished chain termination in the presence of 2',3'-dideoxycytidine 5'-triphosphate and other drugs.
    Gu Z; Arts EJ; Parniak MA; Wainberg MA
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2760-4. PubMed ID: 7535930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the K65R and K65R/M184V reverse transcriptase mutations in subtype C HIV on enzyme function and drug resistance.
    Xu HT; Martinez-Cajas JL; Ntemgwa ML; Coutsinos D; Frankel FA; Brenner BG; Wainberg MA
    Retrovirology; 2009 Feb; 6():14. PubMed ID: 19210791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A loss of viral replicative capacity correlates with altered DNA polymerization kinetics by the human immunodeficiency virus reverse transcriptase bearing the K65R and L74V dideoxynucleoside resistance substitutions.
    Deval J; Navarro JM; Selmi B; Courcambeck J; Boretto J; Halfon P; Garrido-Urbani S; Sire J; Canard B
    J Biol Chem; 2004 Jun; 279(24):25489-96. PubMed ID: 15044478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1 reverse transcriptase expressing the K70E mutation exhibits a decrease in specific activity and processivity.
    Miller MD; Lamy PD; Fuller MD; Mulato AS; Margot NA; Cihlar T; Cherrington JM
    Mol Pharmacol; 1998 Aug; 54(2):291-7. PubMed ID: 9687570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of zidovudine-selected human immunodeficiency virus type 1 reverse transcriptase amino acid substitutions on processive DNA synthesis and viral replication.
    Caliendo AM; Savara A; An D; DeVore K; Kaplan JC; D'Aquila RT
    J Virol; 1996 Apr; 70(4):2146-53. PubMed ID: 8642636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K65R mutation of human immunodeficiency virus type 1 reverse transcriptase encodes cross-resistance to 9-(2-phosphonylmethoxyethyl)adenine.
    Gu Z; Salomon H; Cherrington JM; Mulato AS; Chen MS; Yarchoan R; Foli A; Sogocio KM; Wainberg MA
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1888-91. PubMed ID: 7486942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominance of the E89G substitution in HIV-1 reverse transcriptase in regard to increased polymerase processivity and patterns of pausing.
    Quan Y; Inouye P; Liang C; Rong L; Götte M; Wainberg MA
    J Biol Chem; 1998 Aug; 273(34):21918-25. PubMed ID: 9705331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent defects in processive DNA synthesis, strand transfer, and primer elongation of Met-184 mutants of HIV-1 reverse transcriptase derive solely from a dNTP utilization defect.
    Gao L; Hanson MN; Balakrishnan M; Boyer PL; Roques BP; Hughes SH; Kim B; Bambara RA
    J Biol Chem; 2008 Apr; 283(14):9196-205. PubMed ID: 18218634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Error-prone polymerization by HIV-1 reverse transcriptase. Contribution of template-primer misalignment, miscoding, and termination probability to mutational hot spots.
    Bebenek K; Abbotts J; Wilson SH; Kunkel TA
    J Biol Chem; 1993 May; 268(14):10324-34. PubMed ID: 7683675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative enzymatic study of HIV-1 reverse transcriptase resistant to 2',3'-dideoxynucleotide analogs using the single-nucleotide incorporation assay.
    Ueno T; Mitsuya H
    Biochemistry; 1997 Feb; 36(5):1092-9. PubMed ID: 9033399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A drug resistance mutation in the inhibitor binding pocket of human immunodeficiency virus type 1 reverse transcriptase impairs DNA synthesis and RNA degradation.
    Fan N; Rank KB; Slade DE; Poppe SM; Evans DB; Kopta LA; Olmsted RA; Thomas RC; Tarpley WG; Sharma SK
    Biochemistry; 1996 Jul; 35(30):9737-45. PubMed ID: 8703945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermostable HIV-1 group O reverse transcriptase variants with the same fidelity as murine leukaemia virus reverse transcriptase.
    Barrioluengo V; Alvarez M; Barbieri D; Menéndez-Arias L
    Biochem J; 2011 Jun; 436(3):599-607. PubMed ID: 21446917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced dNTP interaction of human immunodeficiency virus type 1 reverse transcriptase promotes strand transfer.
    Operario DJ; Balakrishnan M; Bambara RA; Kim B
    J Biol Chem; 2006 Oct; 281(43):32113-21. PubMed ID: 16926150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro.
    Ji X; Klarmann GJ; Preston BD
    Biochemistry; 1996 Jan; 35(1):132-43. PubMed ID: 8555166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus 1 reverse transcriptase. Template binding, processivity, strand displacement synthesis, and template switching.
    Huber HE; McCoy JM; Seehra JS; Richardson CC
    J Biol Chem; 1989 Mar; 264(8):4669-78. PubMed ID: 2466838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.
    Back NK; Nijhuis M; Keulen W; Boucher CA; Oude Essink BO; van Kuilenburg AB; van Gennip AH; Berkhout B
    EMBO J; 1996 Aug; 15(15):4040-9. PubMed ID: 8670908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reverse transcriptase mutation K65N confers a decreased replication capacity to HIV-1 in comparison to K65R due to a decreased RT processivity.
    Chunduri H; Crumpacker C; Sharma PL
    Virology; 2011 May; 414(1):34-41. PubMed ID: 21459401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid kinetic analysis of a point mutant of HIV-1 reverse transcriptase lacking ribonuclease H activity.
    Dudding LR; Mizrahi V
    Biochemistry; 1993 Jun; 32(23):6116-20. PubMed ID: 7685188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.